Soligenix
SNGX
#10565
Rank
C$9.45 M
Marketcap
C$0.64
Share price
7.17%
Change (1 day)
-75.05%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -C$17.45 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$13.03 Million a decrease over its 2023 earnings that were of -C$10.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$17.45 Million33.96%
2024 -C$13.03 Million22.96%
2023 -C$10.6 Million-45.74%
2022 -C$19.52 Million11.88%
2021 -C$17.45 Million-32.37%
2020 -C$25.8 Million83.18%
2019 -C$14.09 Million11.57%
2018 -C$12.63 Million19.29%
2017 -C$10.59 Million33%
2016 -C$7.96 Million-19.7%
2015 -C$9.91 Million5.16%
2014 -C$9.43 Million
2010 -C$10.64 Million26.12%
2009 -C$8.44 Million75.1%
2008 -C$4.82 Million-45.38%
2007 -C$8.82 Million-22.84%
2006 -C$11.43 Million66.15%
2005 -C$6.88 Million-16.65%
2004 -C$8.25 Million13.28%
2003 -C$7.29 Million-11.88%
2002 -C$8.27 Million-59.44%
2001 -C$20.38 Million378.18%
2000 -C$4.27 Million-38.53%
1999 -C$6.94 Million-18.43%
1998 -C$8.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.19 B-210,134.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.75 B-85,726.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.67 B-62,017.23%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-C$25.3 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$58.19 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.16 B-18,460.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-C$3.84 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.23 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA